Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Linking dementia pathology and alteration in brain activation to complex daily functional decline during the preclinical dementia stage

Award Number: R01AG082188
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2023
PERIOD OF PERFORMANCE END DATE: 04/30/2028

Group Awards By:

View Award Description

Linking dementia pathology and alteration in brain activation to complex daily functional decline during the preclinical dementia stage - Abstract: Progressive difficulty in performing everyday functional activities is a key diagnostic feature of dementia syndromes. However, not much is known about the neural signature of functional decline, particularly during the very early stages of dementia. Early intervention before overt impairment is observed offers the best hope of reducing the burdens of Alzheimer’s disease and other dementias. But to justify early intervention, those at risk need to be detected earlier and more accurately. Decline in complex daily function (CdF) such as managing medications has been reported to precede impairment in basic activities of daily living (e.g., eating, dressing). Our goal is to establish the neural signature of decline in CdF during the preclinical dementia period. Gait is central to many CdF and community-based activities.2,3 Hence, to elucidate the neural signature of CdF, we validated a novel electroencephalographic (EEG) approach to measure gait-related brain activation while participants perform complex gait based functional tasks. Our hypothesis is that dementia-related pathology during the preclinical period activates a unique gait-related EEG pattern that predicts subsequent decline in CdF. We provide preliminary findings showing that older adults endorsing CdF limitations can be characterized by a unique gait-related neural signature: weaker sensorimotor and stronger motor control activation. This subsample also had smaller brain volume and WMH in regions affected early by dementia and engaged in less physical exercise. We propose a prospective observational cohort study in cognitively unimpaired older adults with and without subclinical Alzheimer’s disease (plasma amyloid-β [Aβ]) and vascular (white matter hyperintensities [WMH]) pathologies. Our aims are to 1) establish the unique gait-related EEG activation as the neural signature and predictor of decline in CdF during the preclinical dementia period; 2) determine associations between dementia-related pathologies and incidence of neural signature of CdF; 3) establish associations between a dementia risk factor, physical inactivity, and the neural signature of CdF. By establishing the clinical relevance and biological basis of the neural signature of CdF decline, we aim to improve prediction during the preclinical stages of Alzheimer’s diseases and other dementias. Our approach has important research and translational implications because gait-related EEG protocols are relatively inexpensive and portable, and predicting CdF decline may have real world benefits. 1


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $748,373 )
2026	2026	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Aging Research	000	4	4/28/2026	NON-COMPETING CONTINUATION	$748,373
														Subtotal = $748,373

Issue Date FY: 2025 ( Subtotal = $767,025 )
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Aging Research	001	3	6/13/2025	NON-COMPETING CONTINUATION	$62,613
2025	2025	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Aging Research	000	3	4/4/2025	NON-COMPETING CONTINUATION	$704,412
														Subtotal = $767,025

Issue Date FY: 2024 ( Subtotal = $813,807 )
2024	2024	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Aging Research	000	2	4/25/2024	NON-COMPETING CONTINUATION	$813,807
														Subtotal = $813,807

Issue Date FY: 2023 ( Subtotal = $829,419 )
2023	2023	ALBERT EINSTEIN COLLEGE OF MEDICINE	1300 MORRIS PARK AVE	BRONX	NY	10461	BRONX	USA	Aging Research	000	1	4/24/2023	NEW	$829,419
														Subtotal = $829,419

Grand Total All Awards = $3,158,624

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Linking dementia pathology and alteration in brain activation to complex daily functional decline during the preclinical dementia stage

Award Number: R01AG082188

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2023

PERIOD OF PERFORMANCE END DATE: 04/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer